163 related articles for article (PubMed ID: 23907409)
1. Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab-bendamustine.
García-Muñoz R; García DK; Roldán-Galiacho V; Merchante-Andreu M; Campeny-Najara A; Rabasa P
Ann Hematol; 2014 Apr; 93(4):699-702. PubMed ID: 23907409
[No Abstract] [Full Text] [Related]
2. [Toxicodermia by bendamustine: development of a desensization protocol].
Sangrador Pelluz C; Luis Hidalgo MM; Martínez García M; Pérez-Serrano Lainosa MD; Soler Company E
Farm Hosp; 2013; 37(5):421-3. PubMed ID: 24128107
[No Abstract] [Full Text] [Related]
3. Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab.
García Muñoz R; Izquierdo-Gil A; Muñoz A; Roldan-Galiacho V; Rabasa P; Panizo C
Ann Hematol; 2014 Nov; 93(11):1879-87. PubMed ID: 24951124
[TBL] [Abstract][Full Text] [Related]
4. Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
Zaja F; Mian M; Volpetti S; Visco C; Sissa C; Nichele I; Castelli M; Ambrosetti A; Puglisi S; Fanin R; Cortelazzo S; Pizzolo G; Trentin L; Rodeghiero F; Paolini R; Vivaldi P; Sancetta R; Isola M; Semenzato G
Am J Hematol; 2013 Nov; 88(11):955-60. PubMed ID: 23861234
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia.
Haskova Z; Whitacre MN; Dede KA; Lee JM; Trulli SH; Ciucci M; Toso JF; White JR; Jonak ZL
Br J Haematol; 2012 Feb; 156(3):402-4. PubMed ID: 21848524
[No Abstract] [Full Text] [Related]
6. Bendamustine-induced "flagellate dermatitis".
Mahmoud BH; Eide MJ
Dermatol Online J; 2012 Nov; 18(11):12. PubMed ID: 23217953
[TBL] [Abstract][Full Text] [Related]
7. Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
Fischer K; Cramer P; Busch R; Böttcher S; Bahlo J; Schubert J; Pflüger KH; Schott S; Goede V; Isfort S; von Tresckow J; Fink AM; Bühler A; Winkler D; Kreuzer KA; Staib P; Ritgen M; Kneba M; Döhner H; Eichhorst BF; Hallek M; Stilgenbauer S; Wendtner CM
J Clin Oncol; 2012 Sep; 30(26):3209-16. PubMed ID: 22869884
[TBL] [Abstract][Full Text] [Related]
8. Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
Fischer K; Cramer P; Busch R; Stilgenbauer S; Bahlo J; Schweighofer CD; Böttcher S; Staib P; Kiehl M; Eckart MJ; Kranz G; Goede V; Elter T; Bühler A; Winkler D; Kneba M; Döhner H; Eichhorst BF; Hallek M; Wendtner CM
J Clin Oncol; 2011 Sep; 29(26):3559-66. PubMed ID: 21844497
[TBL] [Abstract][Full Text] [Related]
9. Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia.
Goldschmidt N; Gural A; Ben-Yehuda D; Gatt ME
Cancer Chemother Pharmacol; 2013 Sep; 72(3):709-13. PubMed ID: 23907444
[TBL] [Abstract][Full Text] [Related]
10. Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study.
Iannitto E; Morabito F; Mancuso S; Gentile M; Montanini A; Augello A; Bongarzoni V; D'Arco A; Di Renzo N; Fazzi R; Franco G; Marasca R; Mulè A; Musso M; Musto P; Pennese E; Piccin A; Rota-Scalabrini D; Visani G; Rigacci L
Br J Haematol; 2011 May; 153(3):351-7. PubMed ID: 21371003
[TBL] [Abstract][Full Text] [Related]
11. Bendamustine in the treatment of chronic lymphocytic leukemia.
Knauf W
Expert Rev Anticancer Ther; 2009 Feb; 9(2):165-74. PubMed ID: 19192955
[TBL] [Abstract][Full Text] [Related]
12. Making advances in first-line chronic lymphocytic leukemia treatment.
Wierda WG
J Clin Oncol; 2012 Sep; 30(26):3162-4. PubMed ID: 22869876
[No Abstract] [Full Text] [Related]
13. Bendamustine in chronic lymphocytic leukemia: the future is combination therapy.
Friedberg JW
Leuk Lymphoma; 2009 Sep; 50(9):1399-400. PubMed ID: 19811324
[No Abstract] [Full Text] [Related]
14. Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect.
Malipatil B; Ganesan P; Sundersingh S; Sagar TG
Hematol Oncol Stem Cell Ther; 2011; 4(4):157-60. PubMed ID: 22198186
[TBL] [Abstract][Full Text] [Related]
15. [Current and future indications for bendamustine: chronic lymphocytic leukemia, indolent lymphoma, mantle cell lymphoma and diffuse large B-cell lymphomas].
Hallek M; Knauf W; Dreyling M; Trümper L
Onkologie; 2013; 36 Suppl 1():11-8. PubMed ID: 23445758
[No Abstract] [Full Text] [Related]
16. The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.
Nordstrom BL; Knopf KB; Teltsch DY; Engle R; Beygi H; Sterchele JA
Leuk Lymphoma; 2014 Jun; 55(6):1266-73. PubMed ID: 23987821
[TBL] [Abstract][Full Text] [Related]
17. Bendamustine/mitoxantrone/rituximab: a short remission induction chemoimmunotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemia.
Weide R; Mergenthaler U; Friesenhahn V; Kleboth K; Heymanns J; Thomalla J; Köppler H
Leuk Lymphoma; 2009 Sep; 50(9):1468-74. PubMed ID: 21049589
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial.
Ujjani C; Cheson B
Future Oncol; 2011 Jan; 7(1):9-14. PubMed ID: 21174533
[TBL] [Abstract][Full Text] [Related]
19. [Chronic lymphocytic leukemia].
Aoki S
Rinsho Ketsueki; 2014 Feb; 55(2):213-22. PubMed ID: 24598189
[No Abstract] [Full Text] [Related]
20. Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group.
Cuneo A; Marchetti M; Barosi G; Billio A; Brugiatelli M; Ciolli S; Laurenti L; Mauro FR; Molica S; Montillo M; Zinzani P; Tura S
Leuk Res; 2014 Nov; 38(11):1269-77. PubMed ID: 25063524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
